Bio Pharma In India
- All
- News
'Bio Pharma In India' - 2 News Result(s)
-
US Pharma Firm HDT Bio Begins Phase III Trial Of Covid Vaccine In India
US-based bio-pharmaceutical company HDT Bio Corp on Wednesday announced the start of Phase III trial of its COVID-19 vaccine in India.
-
Aurobindo Pharma Gets USFDA Nod for Generic Osteoporosis Drug
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
'Bio Pharma In India' - 2 News Result(s)
-
US Pharma Firm HDT Bio Begins Phase III Trial Of Covid Vaccine In India
US-based bio-pharmaceutical company HDT Bio Corp on Wednesday announced the start of Phase III trial of its COVID-19 vaccine in India.
-
Aurobindo Pharma Gets USFDA Nod for Generic Osteoporosis Drug
The approval by the US FDA for Raloxifene Hydrochloride tablets is for strength of 60 mg, which is bio and therapeutically equivalent to the reference listed drug product (RLD) Evista, 60 mg of Eli Lilly, the company said in a statement.
